Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

November 30, 1999

Conditions

Cervical Cancer

Interventions

BIOLOGICAL

human papillomavirus 16 E7 peptide

PROCEDURE

in vitro-treated peripheral blood stem cell transplantation

Trial Locations (1)

St. Elizabeth's Medical Center, Boston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Steward St. Elizabeth's Medical Center of Boston, Inc.

OTHER

NCT00003977 - Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer | Biotech Hunter | Biotech Hunter